ClinicalTrials.Veeva

Menu

Understanding Daily Changes in BDD Risk Using Smartphones

Mass General Brigham logo

Mass General Brigham

Status

Completed

Conditions

Body Dysmorphic Disorders

Treatments

Other: None, observational study only (no interventions)

Study type

Observational

Funder types

Other

Identifiers

NCT04254575
2019P002041

Details and patient eligibility

About

Body dysmorphic disorder (BDD) is associated with high risk for suicide attempts (22-28%) and substance use disorders (49%), underscoring the importance of accurate, real-time risk detection in BDD. This study aims to use smartphone-based digital phenotyping to develop and validate unobtrusive, time-sensitive, and ecologically valid measures of key risk factors for suicide and substance misuse in BDD: negative affect states. As next steps, this research can be extended to detect risk transdiagnostically, with the goal of enabling just-in-time interventions to target suicide and substance misuse across psychiatric illnesses.

Enrollment

87 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Adults age >=18
  • Current primary diagnosis of BDD
  • BDD severity >= moderate
  • Living in US
  • English proficiency
  • Owns an Android or iOS (Apple) smartphone
  • Has regular Wifi-enabled internet access for data downloads

Trial design

87 participants in 1 patient group

body dysmorphic disorder (BDD)
Description:
Adults with a current primary diagnosis of body dysmorphic disorder (BDD)
Treatment:
Other: None, observational study only (no interventions)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems